Let’s work together to improve clinical trial transparency — and health around the world.

Keeping up with clinical trial transparency is no easy feat. Government regulations constantly change. Knowing what compliance data needs to be disclosed, when, and how, isn’t always clear. Finding suitable recruiting trials can be extremely challenging for patients and their families. And properly disclosing results to study participants, researchers, and the general public? That can have its own set of hurdles.

TrialScope is the answer. Through extensive industry expertise and a proven technology platform, we help sponsors like you navigate the journey toward transparency and compliance with complete confidence.

Work with our solutions to optimize the efficiency of your disclosure activities, foster a more informed, engaged patient community, and connect the dots for accelerated study recruitment.

One platform. Unlimited potential. Let’s get started.

Partner with us.
And let’s work together to realize
a new standard in complete
clinical trial transparency.

Meet the team transforming trial transparency.

With a wealth of experience that spans technology, healthcare, life sciences and pharmaceuticals, the TrialScope leadership team is uniquely qualified to lead the charge toward greater trial transparency. Get to know the people behind the movement.

Jeff is a serial healthcare entrepreneur with over 20 years of pharmaceutical experience. Before taking over as TrialScope CEO in 2018, Jeff served on the Company’s Board of Directors for more than two years.

Prior to TrialScope, Jeff was the founder of two healthcare technology companies, HeroLinx and Verilogue. HeroLinx was an online crowdsourcing platform for accelerating clinical trial awareness and patient recruiting. Verilogue, which was acquired by Publicis (PUB:FP), is the global software leader in the capture and linguistic analysis of physician-patient exam room dialogues.

Jeff serves on the Board of Directors for three rapidly growing venture-backed companies: Analytical Wizards, Signallamp Health and Ripple Science. He also previously served on the Board of Directors for iContracts (acquired by RLDatix) and he remains an investor/advisor to other early-stage companies.

Jeff holds a BS in Economics from the Wharton School at the University of Pennsylvania, and is the co-author of a method and system patent for analyzing the effectiveness of marketing strategies.

Matt has nearly 20 years of experience in financial operations and management in various organizations ranging from fortune 500 companies to small venture-backed organizations.

Most recently he served as the COO for Verilogue, a venture-backed tech-enabled research company, with a successful exit in 2013.  

Matt started his career at KPMG spending nearly 5 years performing financial audits on mid-sized public companies.  These companies covered a wide range of industries including software, manufacturing, retail, and hi-tech development.  Matt then moved on to serve 7 years as the Vice President of Finance and Land Development for Pulte Homes, the largest national homebuilder in America, overseeing all finance, legal, HR, and land issues for the Delaware Valley Area.  Matt served as the CFO of STRATIS IoT, a venture-backed software startup, overseeing a Series A capital raise and the implementation of various software solutions including SalesForce.com, Pardot and automated HR tools.  Matt was also the Vice President of Finance at Bohler Engineering overseeing the implementation of a new ERP system covering 13 offices in 7 states.

Matt received a bachelor’s degree in accounting from The Pennsylvania State University and received his CPA license from the state of Pennsylvania (active 2003-2006).

Thomas has more than 17 years of experience with performance and content management solutions, specializing in applications for life sciences such as clinical trial disclosure, structured product labelling and submissions management and has been on the PharmaCM team since 2007.

Prior to the acquisition of PharmaCM by TrialScope, Thomas served as the General Manager of PharmaCM at Deloitte and as the Director of PharmaCM Product Management at Intrasphere Technologies. Before joining Intrasphere, Thomas worked in leadership, client-facing positions for Revelwood Inc. and Shepherd Systems, focused on performance management solutions.

Dave has more than 20 years of experience in the Life Sciences industry where he has focused on building successful client services organizations as well as developing process oriented operations. He has successfully contributed to the growth and expansion of several companies through a customer first focus.

Dave’s Life Sciences background includes roles such as Vice President and General Manager of ArisGlobal’s eClinical Business Unit as well as holding a senior level position at eResearchTechnologies, Inc., where he served as the General Manager & Senior Vice President of the eClinical Group. Prior to joining TrialScope, Dave also worked for several early-stage companies where he owned P&L responsibility as a business unit head as well as serving as the President & CEO for a publicly traded company. He has consistently contributed to the development of key areas of the business, including but not limited to, sales and marketing, professional services, product development, customer support, and operations. Dave graduated from Pennsylvania State University with a B.S. in Accounting and a Minor in Economics.

Naor is an accomplished B2B marketing leader with experience at high-growth global companies spanning healthcare software and technology, life sciences, marketing research, and workspace design.

He believes that great marketing essentially starts with a clear understanding of customer passions and pain points, and that helping them solve everyday business challenges via thought leadership is the pathway to building value and brand preference.

Naor previously led marketing at remarkable healthcare technology companies, including SmartLinx, CRF Health, and Verilogue.

He holds a B.S. in Marketing from the Rutgers Business School at Rutgers University, and a Marketing Strategy Certification from the Cornell University Samuel Curtis Johnson Graduate School of Management.

Francine is responsible for helping TrialScope customers meet and exceed current disclosure expectations globally, giving them the tools they need to meet all the requirements in this evolving industry.

Francine also dedicates her time building relationships with external stakeholders – including sponsors, investigators, regulators, and transparency and patient advocates – to help align the goals and expectations of these groups, as well as help identify more consistent ways sponsors can meet industry standards. Prior to her role as Vice President of Global Transparency, Francine served as Director of Product Management at TrialScope. She also serves as Chair of the Drug Information Association (DIA) Clinical Trial Disclosure Community.

Mike is a software developer and entrepreneur with over 8 years of experience developing solutions for patients.

Mike was an Associate Director at the Michael J. Fox Foundation for Parkinson’s Research where he oversaw the development of Fox Trial Finder and Fox Insight, two platforms to help the Parkinson’s community connect with clinical trials and track their disease over time. Mike went on to join Epion Health as Lead Developer where he and his team developed a solution to simplify the check-in process for patients and their medical providers. Mike founded Clinical Trial Connect in 2015 to bring clinical trial matching capabilities to more patient advocacy groups and scaled the platform to support over 20 national patient advocacy groups. Clinical Trial Connect was acquired by TrialScope in October 2019 and Mike looks forward to continuing to promote clinical trial awareness and helping patients in their journey.

Board of Directors

James C. Walker has been working in the pharmaceutical industry for 20 years. He is the founder of Octagon Research Solutions, Inc. Prior to founding Octagon, he worked as the Senior Manager of Worldwide Regulatory Affairs for the Schering-Plough Corporation (“Schering”).

While at Schering, he was responsible for clinical and pre-clinical in the antihistamine, central nervous system, and critical care therapeutic areas.

Prior to joining Schering, Mr. Walker worked across multiple therapeutic areas in the Regulatory Affairs/Clinical and Clinical Quality Assurance department at the R.W. Johnson Pharmaceutical Research Institute (PRI). Mr. Walker has extensive experience in and knowledge of all phases of clinical research and both FDA and European regulations. He is skilled at process improvement and providing insight across multiple disciplines within drug development. Mr. Walker holds a B.S. in Biological Sciences from Villanova University, a Masters in Environmental Sciences from Rutgers University, and an M.B.A. from Duke University.

Michael has nearly 20 years of venture investing, corporate finance and entrepreneurship with software, e-commerce and financial services organizations. Michael leads Edison’s Fintech practice. He also guides the investment team in Pennsylvania and Delaware. Michael is a frequent speaker at entrepreneurial events, technology conferences and financing seminars.

Michael began his career as an investment banker with Credit Suisse First Boston where he advised large retail and consumer products companies on numerous M&A and financing transactions. In 1999, Michael left CSFB to launch E*OFFERING, a venture-backed online investment bank affiliated with E*TRADE. He launched several new online products, including the first web-based roadshow for retail investors. E*OFFERING was acquired one year after its launch by SoundView Technology Group, where he remained to lead the firm’s internet & e-commerce investment banking franchise.

Michael is active in regional venture, entrepreneurial and technology organizations, including PACT, ACG and Early Stage East. He is currently Co-President of Wharton Private Equity Partners and past Co-Chair of the Wharton Private Equity Conference.

His education includes a BA in Economcs from the University of Pennsylvania, and an MBA from The Wharton School.

Jeff is a serial healthcare entrepreneur with over 20 years of pharmaceutical experience. Before taking over as TrialScope CEO in 2018, Jeff served on the Company’s Board of Directors for more than two years.

Prior to TrialScope, Jeff was the founder of two healthcare technology companies, HeroLinx and Verilogue. HeroLinx was an online crowdsourcing platform for accelerating clinical trial awareness and patient recruiting. Verilogue, which was acquired by Publicis (PUB:FP), is the global software leader in the capture and linguistic analysis of physician-patient exam room dialogues.

Jeff serves on the Board of Directors for three rapidly growing venture-backed companies: Analytical Wizards, Signallamp Health and Ripple Science. He also previously served on the Board of Directors for iContracts (acquired by RLDatix) and he remains an investor/advisor to other early-stage companies.

Jeff holds a BS in Economics from the Wharton School at the University of Pennsylvania, and is the co-author of a method and system patent for analyzing the effectiveness of marketing strategies.

Larry joined iPipeline in 2002, and served as President and CEO of the company through July 2008. Larry transitioned to the Chief Operating Officer and Chief Financial Officer positions in July 2008 in connection with a combined recapitalization of iPipeline and an acquisition of a key partner. During his tenure, Larry has been a key driver of growing iPipeline from $1 million in revenue to over $150 million and completing 10 strategic acquisitions in the US, UK and Canada.

Larry has raised over $0.5 billion in equity and debt proceeds for the Company and it investors for acquisitions, working capital and highly successful exits for NewSpring Capital, Alimont (fka Fidelity Ventures), Technology Crossover Ventures, Square 1 Bank, Capital One Bank and Wells Fargo.

Prior to iPipeline, Larry was a Vice President for ICG, where he played an instrumental role in preparing ICG for its 1999 initial public offering. During this time, Larry was directly involved with organizing and implementing ICG’s finance function, including raising over $1.6 billion through multiple issuances of publicly traded securities, as well as bank and private financings.

Larry has also held management positions with Safeguard Scientifics and worked as a CPA with PWC specializing in insurance and financial services. Larry’s prior board and public service have included The Sycamore Group, Philadelphia Children’s Alliance, ARI Mutual Insurance Company, and coaching girls soccer and basketball. Larry currently serves as a board director for Trial Scope (including Compensation Cte and Chair of Audit Cte).

Larry graduated in 1993 from La Salle University in Philadelphia, Pennsylvania with a Bachelor of Science degree. He has two daughters and resides in West Chester, PA.

Marc Lederman is a co-founder of NewSpring and a General Partner of the Firm’s dedicated growth equity funds. He serves as a member of the investment committee of all NewSpring Growth and NewSpring Mezzanine funds.

Marc has an extensive background in finance, investing, consulting, and accounting and was a Certified Public Accountant. Prior to co-founding NewSpring, he was a Manager in the Business Assurance and Advisory Services Group of Deloitte. Marc is an active member of the Mid-Atlantic region’s private equity and venture capital community.

He received a BS in Accountancy from Villanova University and an MBA from The Wharton School of the University of Pennsylvania.

Dispatches from the frontlines of trial transparency.

There’s never a dull moment at TrialScope. As we work to establish — and support — a new standard of clinical trial transparency, you’ll find the latest updates here, from product releases to events, partnerships, presentations and more. Stay in the loop!

Be a part of the clinical trial
transparency revolution.

Because we’re always innovating, we’re always on the lookout for imaginative, customer-
centric, roll-up-your-sleeves people to join the team. Explore our current career
opportunities.

TrialScope Support

Our team is just a call or email away.

Our customer support team is here to assist you, troubleshoot and answer any questions you may have. Let us know how we can help through the TrialScope Community portal below.